Wide Ranks

MNMD

Mind Medicine (MindMed) Inc.

8.26

Top Statistics
Market Cap 605 M Forward PE -5.57 Revenue Growth 0.00 %
Current Ratio 9.00 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 295 M Total Cash Per Share 4.03 Total Debt 24 M
Total Debt To Equity 9.27 Current Ratio 9.00 Book Value Per Share 3.21
All Measures
Short Ratio 676.00 % Message Board Id finmb_631045282 Shares Short Prior Month 10 M
Return On Equity -0.5461 City New York Uuid 82effaa6-cea3-362e-b9a1-33a692529ba0
Previous Close 8.11 First Trade Date Epoch Utc 1 B Book Value 3.21
Beta 2.33 Total Debt 24 M Volume 1 M
Price To Book 2.57 Last Split Date 1 B Fifty Two Week Low 2.92
Total Cash Per Share 4.03 Shares Short Previous Month Date 1 B Target Median Price 20.50
Audit Risk 8 Max Age 86400 Recommendation Mean 1.44
Sand P52 Week Change 0.3133 Target Mean Price 26.62 Net Income To Common -97802000
Short Percent Of Float 0.1372 Implied Shares Outstanding 73 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 295 M Next Fiscal Year End 1 B Held Percent Insiders 0.0114
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 3 Regular Market Previous Close 8.11 Target Low Price 16.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 6.55 Open 8.16
Free Cashflow -40368124 State NY Dividend Yield 0.00 %
Return On Assets -0.2538 Time Zone Short Name EST Board Risk 4
Trailing Eps -1.71 Day Low 7.95 Address1 One World Trade Center
Shares Outstanding 73 M Compensation Risk 10 Price Hint 2
Target High Price 55.00 Website https://www.mindmed.co 52 Week Change 1.50
Average Volume 1 M Forward Eps -1.37 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 887.70 % Last Split Factor 1:15
Regular Market Day High 8.39 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 9.27 Fifty Two Week High 12.22 Day High 8.39
Shares Short 10 M Regular Market Open 8.16 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.1371
Operating Cashflow -74341000 Currency USD Time Zone Full Name America/New_York
Market Cap 605 M Is_nasdaq_100 False Zip 10007
Quote Type EQUITY Industry Biotechnology Long Name Mind Medicine (MindMed) Inc.
Overall Risk 8 Regular Market Day Low 7.95 Held Percent Institutions 0.6812
Current Price 8.26 Address2 Suite 8500 Financial Currency USD
Current Ratio 9.00 Industry Disp Biotechnology Number Of Analyst Opinions 8
Country United States Float Shares 59 M Two Hundred Day Average 7.52
Governance Epoch Date 1 B Enterprise Value 334 M Forward PE -5.57
Regular Market Volume 1 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder.

Mind Medicine (MindMed) Inc. is headquartered in New York, New York.